Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Micreos makes space for $37.5m

Exploiting ETH Zurich research, Micreos is working on a clinical platform that enables the targeted killing of unwanted bacteria only.


Oct 1, 2021

Zylotech reaches Terminus for acquisition

MIT spinout Zylotech has been acquired by Terminus for an undisclosed amount.

Oct 1, 2021

Li-S Energy celebrates market debut

Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.

Sep 30, 2021

Daily deal net: September 30, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 30, 2021

HSU and UC Davis launch tech centre

Humboldt State University has joined forces with UC Davis to create an incubator focused on agtech and biotech companies in northern California.

Sep 30, 2021

Tolbert takes trip to URVentures

University of Rochester has rehired Harl Tolbert, currently with Pennsylvania State University, as associate vice-president of URVentures.

Sep 30, 2021

Kytopen constructs $30m series A

The Engine has returned once more to back a $30m round for Kytopen, having first invested in the MIT spinout in 2017.

Sep 29, 2021

Daily deal net: September 28, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 28, 2021

EIF backs Central Europe-focused fund

The European Investment Fund will provide half the capital for the $59m i&i Biotech Fund I, which will operate out of the Czech Republic.

Sep 28, 2021

Lucid Diagnostics lines up IPO

Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.

Sep 28, 2021

Garuda gets underway with $72m

Co-founded by Harvard faculty, Garuda has launched with $72m in series A financing to advance blood stem cell therapies.

Sep 24, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here